glyburide has been researched along with fibrinogen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, WC; Lebovitz, H; Marbury, T; Strange, P | 1 |
Bulmer, K; Denver, AE; Emeis, JJ; Mohamed-Ali, V; Panahloo, A; Stehouwer, C; Yudkin, JS | 1 |
2 trial(s) available for glyburide and fibrinogen
Article | Year |
---|---|
Repaglinide versus glyburide: a one-year comparison trial.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Piperidines; Prospective Studies; Triglycerides; United States; United States Food and Drug Administration | 1999 |
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.
Topics: Acute-Phase Proteins; Albuminuria; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endothelium, Vascular; Female; Fibrinogen; Fibronectins; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Interleukin-6; Male; Middle Aged; Sulfonylurea Compounds; Thrombomodulin; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2000 |